Literature DB >> 15963331

West Nile Virus Encephalitis.

James L Dean1, Brandon J Palermo.   

Abstract

West Nile virus (WNV) is a small RNA virus. It was first isolated in the blood of a febrile woman in the West Nile district of Uganda in 1937. Although WNV has caused human disease in Africa and Europe since its identification, the first documented human infections occurred in the United States in 1999. Wild birds are the reservoir for WNV, and most transmission to humans occurs after the bite of an infected mosquito. In humans, 80% of infections are asymptomatic and nearly 20% cause a mild self-limiting illness called WNV fever. Less than 1% will develop central nervous system (CNS) infection, which manifests as meningitis, encephalitis, or acute flaccid paralysis. The case fatality rate for CNS infection is approximately 15%. Human vaccine is not available. Personal mosquito protection remains the best prevention, and treatment is supportive.

Entities:  

Year:  2005        PMID: 15963331     DOI: 10.1007/s11908-005-0062-5

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.663


  25 in total

1.  The outbreak of West Nile virus infection in the New York City area in 1999.

Authors:  D Nash; F Mostashari; A Fine; J Miller; D O'Leary; K Murray; A Huang; A Rosenberg; A Greenberg; M Sherman; S Wong; M Layton
Journal:  N Engl J Med       Date:  2001-06-14       Impact factor: 91.245

Review 2.  Ocular manifestations of West Nile virus.

Authors:  Sophie J Bakri; Peter K Kaiser
Journal:  Curr Opin Ophthalmol       Date:  2004-12       Impact factor: 3.761

3.  Co-existence of cerebral cysticercosis with Japanese encephalitis: a prognostic modulator.

Authors:  A Desai; S K Shankar; P N Jayakumar; A Chandramuki; M Gourie-Devi; B V Ravikumar; V Ravi
Journal:  Epidemiol Infect       Date:  1997-04       Impact factor: 2.451

Review 4.  West Nile virus: a primer for the clinician.

Authors:  Lyle R Petersen; Anthony A Marfin
Journal:  Ann Intern Med       Date:  2002-08-06       Impact factor: 25.391

Review 5.  West Nile virus.

Authors:  Grant L Campbell; Anthony A Marfin; Robert S Lanciotti; Duane J Gubler
Journal:  Lancet Infect Dis       Date:  2002-09       Impact factor: 25.071

6.  Phylogenetic analysis of a human isolate from the 2000 Israel West Nile virus epidemic.

Authors:  Thomas Briese; Andrew Rambaut; Melissa Pathmajeyan; Jihad Bishara; Miriam Weinberger; Silvio Pitlik; W Ian Lipkin
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

7.  B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

Authors:  Michael S Diamond; Bimmi Shrestha; Anantha Marri; Darby Mahan; Michael Engle
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

8.  Visual loss with West Nile virus infection: a wider spectrum of a "new" disease.

Authors:  William Anninger; Martin Lubow
Journal:  Clin Infect Dis       Date:  2004-03-16       Impact factor: 9.079

Review 9.  West Nile encephalitis and myelitis.

Authors:  Karen L Roos
Journal:  Curr Opin Neurol       Date:  2004-06       Impact factor: 5.710

10.  Acute flaccid paralysis and West Nile virus infection.

Authors:  James J Sejvar; A Arturo Leis; Dobrivoje S Stokic; Jay A Van Gerpen; Anthony A Marfin; Risa Webb; Maryam B Haddad; Bruce C Tierney; Sally A Slavinski; Jo Lynn Polk; Victor Dostrow; Michael Winkelmann; Lyle R Petersen
Journal:  Emerg Infect Dis       Date:  2003-07       Impact factor: 6.883

View more
  1 in total

Review 1.  Emerging and re-emerging viral infections in Europe.

Authors:  Agostino Pugliese; Tiziana Beltramo; Donato Torre
Journal:  Cell Biochem Funct       Date:  2007 Jan-Feb       Impact factor: 3.685

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.